H

Hangzhou ImmuQuad Biotech, LLC.

1 employees

ImmuQuad Biotechnologies is a leading national high-tech enterprise in the field of immunogenomics (TCR/BCR) technology.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Cancer Immunotherapy
BCR-SEQ
TCR-SEQ
Life Science

Date founded

2016

Funding rounds raised

H

Hangzhou ImmuQuad Biotech, LLC. raised undisclosed on October 1, 2020

Investors: Genetron Health, Inc

H

Hangzhou ImmuQuad Biotech, LLC. raised undisclosed on March 1, 2016

Investors: 杭州帮实投资管理有限公司

FAQ